ITC says Apple’s new blood oxygen feature does not infringe Masimo patents

An ITC judge has given Apple a crucial win, ruling that the Apple Watch’s redesigned blood oxygen feature doesn’t infringe Masimo’s patents and can stay on sale in the US.

https://gadgetbond.com/apple-watch-blood-oxygen-masimo-itc-workaround/